BioBridge Global is a San Antonio, Texas-based nonprofit corporation that offers diverse services through its subsidiaries – the South Texas Blood & Tissue Center, QualTex Laboratories, GenCure and the Blood & Tissue Center Foundation.
Principal Investigator(s)
Scott Jones
Development of an assay to determine the exact amount (ng/ml) of anti-D in human plasma samples
For more than 25 years, Biomedical Development Corporation has been bringing commercially-viable products to market by linking promising technologies with vital sources of research funding.
Principal Investigator(s)
Dr. Charles L. Bowden, M.D.
Susan L. McElroy, M.D.
Rif S. El-Mallakh, M.D.
Funded by
National Institute of Mental Health (NIMH)
The goal of this project is to complete the development of a patient-centered software system and mobile app to assist in managing bipolar disorder. The clinical trial (n=120) is a randomized 52 week, blinded rater comparison of KIOS Bipolar to a popular mood charting program.
BioBridge Global is a San Antonio, Texas-based nonprofit corporation that offers diverse services through its subsidiaries – the South Texas Blood & Tissue Center, QualTex Laboratories, GenCure and the Blood & Tissue Center Foundation.
Principal Investigator(s)
Scott Jones
Completed
Development and validation of assays to screen source plasma production pools
EO2 Concepts (EO2), is an advanced wound care technology company.
Principal Investigator(s)
Botero
Funded by
EO2
Collaborating Institutions
Gonzaba Medical Group, San Antonio, TX
During a retrospective study over a period of 20 months in a wound care clinic, the efficacy of using continuous diffusion of oxygen via the TransCu O2 oxygen delivery system in the treatment of toe ulcerations was assessed. The patients in the study received continuous diffusion of oxygen therapy at rates between 3 and 10 mL/hr underneath a moisture balancing dressing, and clinicians attempted to use compression when appropriate.
